Article Versions Notes

Zheng B, Wang Y-X, Wu Z-Y, Li X-W, Qin L-Q, Chen N-Y, Su G-F, Su J-C, Pan C-X. Design, Synthesis and Bioactive Evaluation of Topo I/c-MYC Dual Inhibitors to Inhibit Oral Cancer via Regulating the PI3K/AKT/NF-κB Signaling Pathway. Molecules. 2025; 30(4):894. https://doi.org/10.3390/molecules30040894

Zheng, Bin, Yi-Xiao Wang, Zi-Yan Wu, Xin-Wei Li, Li-Qing Qin, Nan-Ying Chen, Gui-Fa Su, Jun-Cheng Su, and Cheng-Xue Pan. 2025. "Design, Synthesis and Bioactive Evaluation of Topo I/c-MYC Dual Inhibitors to Inhibit Oral Cancer via Regulating the PI3K/AKT/NF-κB Signaling Pathway" Molecules 30, no. 4: 894. https://doi.org/10.3390/molecules30040894

Zheng, B., Wang, Y.-X., Wu, Z.-Y., Li, X.-W., Qin, L.-Q., Chen, N.-Y., Su, G.-F., Su, J.-C., & Pan, C.-X. (2025). Design, Synthesis and Bioactive Evaluation of Topo I/c-MYC Dual Inhibitors to Inhibit Oral Cancer via Regulating the PI3K/AKT/NF-κB Signaling Pathway. Molecules, 30(4), 894. https://doi.org/10.3390/molecules30040894